# A First Time in Human Phase 1 Open-Label Study of the COVIDITY Vaccine Administered by Needle-free Injection

> **NCT05047445** · PHASE1 · UNKNOWN · sponsor: **Scancell Ltd** · enrollment: 80 (estimated)

## Conditions studied

- COVID-19

## Interventions

- **BIOLOGICAL:** COVIDITY (SCOV1 and SCOV2) administered via needle-free intradermal injection
- **BIOLOGICAL:** COVIDITY (SCOV1 and SCOV2) administered via needle-free intramuscular injection
- **BIOLOGICAL:** COVIDITY (SCOV2 only) administered via needle-free intradermal injection to vaccine naive and/or previously vaccinated participants
- **BIOLOGICAL:** COVIDITY (SCOV2 only) administered via needle-free intramuscular injection to vaccine naive and/or previously vaccinated participants
- **BIOLOGICAL:** COVIDITY (SCOV2 only) administered via needle-free intradermal injection to previously infected participants
- **BIOLOGICAL:** COVIDITY (SCOV2 only) administered via needle-free intramuscular injection to previously infected participants

## Key facts

- **NCT ID:** NCT05047445
- **Lead sponsor:** Scancell Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-10-01
- **Primary completion:** 2022-12
- **Final completion:** 2022-12
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2022-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05047445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05047445, "A First Time in Human Phase 1 Open-Label Study of the COVIDITY Vaccine Administered by Needle-free Injection". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT05047445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*